Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Not Applicable

Recruiting

• Conditions: Atrial Septal Defect; Successful Device Closure

• Registration Number: NCT02097758
• Lead Sponsor: Asan Medical Center

Brief Summary

Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study.

Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-03
• Study First Submitted: 2014-03-25
• Study First Submitted QC: 2014-03-26
• Study First Posted: 2014-03-27
• Status Verified: 2023-01
• Last Update Submitted: 2025-02-05
• Last Update Posted: 2025-02-07
• Primary Completion: 2026-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age ≥18 year-old
• Susceptible indication for atrial septal defect closure
• Potential candidate for device closure

Exclusion Criteria

• Poor candidate for device closure: multiple ASDs, ect
• Other heart disease requiring open heart surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Successful device implantation	1 day

Secondary Outcome Measures

Name	Time	Method
Procedure time	during procedure

Trial Locations

Locations (1)

Asan Medical Center; 🇰🇷 Seoul, Korea, Republic of